Hartmut Geiger

Summary

Affiliation: University of Ulm
Country: Germany

Publications

  1. ncbi Aging in the lympho-hematopoietic stem cell compartment
    Hartmut Geiger
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Trends Immunol 30:360-5. 2009
  2. ncbi Targeting erythroblast-specific apoptosis in experimental anemia
    Abhinav Diwan
    Center for Molecular Cardiovascular Research, University of Cincinnati, Cincinnati, OH, USA
    Apoptosis 13:1022-30. 2008
  3. ncbi Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization
    Marnie A Ryan
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center CCHMC, Cincinnati, Ohio, USA
    Nat Med 16:1141-6. 2010
  4. ncbi Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen
    Theodosia A Kalfa
    Division of Hematology Oncology, Oncology, Cincinnati Children s Research Foundation, Cincinnati Children s Hospital Medical Center, MLC 7015 Cincinnati, OH 45229 3039, USA
    Haematologica 95:27-35. 2010
  5. ncbi Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential
    Haiming Xu
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Research Foundation, Cincinnati, OH 45229, USA
    Blood 114:3557-66. 2009
  6. ncbi R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization
    Xun Shang
    Division of Experimental Hematology and Cancer Biology, Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    J Biol Chem 286:24068-78. 2011
  7. ncbi Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation
    Amitava Sengupta
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Proc Natl Acad Sci U S A 108:9957-62. 2011
  8. ncbi Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow
    Linda Yang
    Division of Experimental Hematology and Pathology, Cincinnati Children s Research Foundation, Molecular Developmental Biology Graduate Program, University of Cincinnati, Cincinnati, OH 45229, USA
    Proc Natl Acad Sci U S A 104:5091-6. 2007
  9. ncbi Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential
    Jon P Williams
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Research Foundation, Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Cell Stem Cell 3:658-69. 2008
  10. ncbi Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity
    Hartmut Geiger
    Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
    Nat Med 18:1123-9. 2012

Collaborators

Detail Information

Publications21

  1. ncbi Aging in the lympho-hematopoietic stem cell compartment
    Hartmut Geiger
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Trends Immunol 30:360-5. 2009
    ..Reverting or ameliorating aging of HSCs might be a crucial step to restoring immuno-competence in the elderly...
  2. ncbi Targeting erythroblast-specific apoptosis in experimental anemia
    Abhinav Diwan
    Center for Molecular Cardiovascular Research, University of Cincinnati, Cincinnati, OH, USA
    Apoptosis 13:1022-30. 2008
    ..These results support the concept of targeting erythroblast apoptosis to maximize erythrocyte production in acute anemia, which may be of value in erythropoietin resistance...
  3. ncbi Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization
    Marnie A Ryan
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center CCHMC, Cincinnati, Ohio, USA
    Nat Med 16:1141-6. 2010
    ..Our findings reveal a previously unknown signaling pathway regulating stem cell mobilization and provide a new pharmacological approach for improving HSPC mobilization and thereby transplantation outcomes...
  4. ncbi Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen
    Theodosia A Kalfa
    Division of Hematology Oncology, Oncology, Cincinnati Children s Research Foundation, Cincinnati Children s Hospital Medical Center, MLC 7015 Cincinnati, OH 45229 3039, USA
    Haematologica 95:27-35. 2010
    ..The role of these Rac GTPases in erythropoiesis has not yet been fully elucidated...
  5. ncbi Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential
    Haiming Xu
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Research Foundation, Cincinnati, OH 45229, USA
    Blood 114:3557-66. 2009
    ..Our study defines p190-B as a critical transducer element of HSC self-renewal activity and long-term engraftment, thus suggesting that p190-B is a target for HSC-based therapies requiring maintenance of engraftment phenotype...
  6. ncbi R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization
    Xun Shang
    Division of Experimental Hematology and Cancer Biology, Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    J Biol Chem 286:24068-78. 2011
    ..These results indicate that R-Ras is a critical regulator of Rac signaling required for HPC migration, homing, and mobilization...
  7. ncbi Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation
    Amitava Sengupta
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Proc Natl Acad Sci U S A 108:9957-62. 2011
    ....
  8. ncbi Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow
    Linda Yang
    Division of Experimental Hematology and Pathology, Cincinnati Children s Research Foundation, Molecular Developmental Biology Graduate Program, University of Cincinnati, Cincinnati, OH 45229, USA
    Proc Natl Acad Sci U S A 104:5091-6. 2007
    ..Thus, Cdc42 is a critical coordinator of HSC quiescence maintenance and interaction with the BM niche...
  9. ncbi Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential
    Jon P Williams
    Division of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Research Foundation, Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Cell Stem Cell 3:658-69. 2008
    ..We suggest that expansion of an EGFR-expressing early glial progenitor contributes to neurofibroma formation...
  10. ncbi Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity
    Hartmut Geiger
    Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
    Nat Med 18:1123-9. 2012
    ..These findings suggest that pharmacologic augmentation of the activity of the Thbd-aPC pathway by recombinant Thbd or aPC might offer a rational approach to the mitigation of tissue injury and lethality caused by ionizing radiation...
  11. ncbi Stem cells, aging, niche, adhesion and Cdc42: a model for changes in cell-cell interactions and hematopoietic stem cell aging
    Hartmut Geiger
    Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, Department of Medicine, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Cell Cycle 6:884-7. 2007
    ....
  12. ncbi Quantification of genomic mutations in murine hematopoietic cells
    Hartmut Geiger
    Department of Medicine, University of Cincinnati, Cincinnati, OH, USA
    Methods Mol Biol 506:423-36. 2009
    ....
  13. ncbi Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element
    Hartmut Geiger
    Division of Experimental Hematology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA
    Proc Natl Acad Sci U S A 102:5102-7. 2005
    ....
  14. ncbi The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress
    Deidre Daria
    Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, Department of Medicine, University of Cincinnati, OH 45229, USA
    Blood 111:1894-902. 2008
    ..In summary, Rb is critical for hematopoietic stem and progenitor cell function, localization, and differentiation...
  15. ncbi TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells
    June Li
    Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA
    J Clin Invest 117:3283-95. 2007
    ..We conclude that TNF-alpha exposure creates an environment in which somatically mutated preleukemic stem cell clones are selected and from which unaltered TNF-alpha-hypersensitive Fancc-/- stem cells are purged...
  16. ncbi The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging
    Melissa Dumble
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, and Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, OH, USA
    Blood 109:1736-42. 2007
    ..Thus, alteration of p53 activity affects stem-cell numbers, proliferation potential, and hematopoiesis in older organisms, supporting a model in which aging is caused in part by a decline in tissue stem cell regenerative function...
  17. ncbi Increased hematopoietic stem cell mobilization in aged mice
    Zhenlan Xing
    Division of Experimental Hematology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Blood 108:2190-7. 2006
    ..These results might indicate that stroma-stem cell interactions are dynamic over a lifetime and result in physiologically relevant changes in the biology of primitive hematopoietic cells with age...
  18. ncbi Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells
    Michael D Milsom
    Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, USA
    Cancer Res 68:6171-80. 2008
    ..These studies have direct translational relevance to ongoing clinical gene therapy studies using MGMT(P140K), whereas the novel mechanistic findings are relevant to the basic understanding of DNA repair by MGMT...
  19. ncbi Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis
    Abhinav Diwan
    Center for Molecular Cardiovascular Research and Department of Pediatrics, Children s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45267, USA
    Proc Natl Acad Sci U S A 104:6794-9. 2007
    ..These results suggest that physiological codependence and coordinated regulation of pro- and antiapoptotic Bcl2 family members may represent a general regulatory paradigm in hematopoiesis...
  20. ncbi Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia
    Deepika Bhatla
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Br J Haematol 144:388-94. 2009
    ..59 +/- 12% AA and 55 +/- 14% AC; P = 0.40). These data indicate that children with a low activity CDA genotype are at increased risk of TRM with ara-C based therapy for AML...
  21. ncbi p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
    Ondrej Krejci
    Division of Experimental Hematology, Cincinnati Children s Hospital Medical Center, University of Cincinnati College of Medicine, OH 45226, USA
    Blood 111:2190-9. 2008
    ..It is possible that the superior outcome of t(8;21) patients is partly due to an activated p53 pathway, and that loss of the p53 response pathway is associated with disease progression...